Quarterly report [Sections 13 or 15(d)]

Condensed Statement of Changes in Stockholders??? Equity (Unaudited)

v3.25.3
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Public Stock Offering
At The Market Offering
Common Stock
Common Stock
Public Stock Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
Public Stock Offering
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023       26,329,032            
Beginning balance at Dec. 31, 2023 $ 15,937     $ 3     $ 52,759     $ (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 3,300           3,300      
Sale of Common Stock, net of issuance costs (in shares)           50,000        
Sale of Common Stock, net of issuance costs     $ 76           $ 76  
Stock issuance upon exercise of stock options (in shares)       38,069            
Stock issuance upon exercise of stock options 29           29      
Stock issuance upon vesting of restricted stock unit (in shares)       177,827            
Net loss (14,541)                 (14,541)
Ending balance (in shares) at Sep. 30, 2024       26,594,928            
Ending balance at Sep. 30, 2024 4,801     $ 3     56,164     (51,366)
Beginning balance (in shares) at Jun. 30, 2024       26,562,111            
Beginning balance at Jun. 30, 2024 8,706     $ 3     55,090     (46,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 1,053           1,053      
Stock issuance upon exercise of stock options (in shares)       32,817            
Stock issuance upon exercise of stock options 21           21      
Net loss (4,979)                 (4,979)
Ending balance (in shares) at Sep. 30, 2024       26,594,928            
Ending balance at Sep. 30, 2024 $ 4,801     $ 3     56,164     (51,366)
Beginning balance (in shares) at Dec. 31, 2024 26,960,901     26,960,901            
Beginning balance at Dec. 31, 2024 $ 1,654     $ 3     57,924     (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 3,720           3,720      
Sale of Common Stock, net of issuance costs (in shares)         6,746,386 313,476        
Sale of Common Stock, net of issuance costs $ 1 $ 10,250 494     $ 1   $ 10,250 493  
Stock issuance upon exercise of stock options (in shares) 82,076     50,532            
Stock issuance upon exercise of stock options             1      
Stock issuance upon vesting of restricted stock unit (in shares)       269,432            
Net loss $ (15,713)                 (15,713)
Ending balance (in shares) at Sep. 30, 2025 34,340,727     34,340,727            
Ending balance at Sep. 30, 2025 $ 406     $ 4     72,388     (71,986)
Beginning balance (in shares) at Jun. 30, 2025       34,020,340            
Beginning balance at Jun. 30, 2025 4,182     $ 4     70,909     (66,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock based compensation expense 1,433           1,433      
Sale of Common Stock, net of issuance costs (in shares)           29,138        
Sale of Common Stock, net of issuance costs     $ 45           45  
Stock issuance upon exercise of stock options (in shares)       21,817            
Stock issuance upon exercise of stock options 1               $ 1  
Stock issuance upon vesting of restricted stock unit (in shares)       269,432            
Net loss $ (5,255)                 (5,255)
Ending balance (in shares) at Sep. 30, 2025 34,340,727     34,340,727            
Ending balance at Sep. 30, 2025 $ 406     $ 4     $ 72,388     $ (71,986)